<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000643596"><TermName>anti-TRAIL R1-mAb</TermName><TermPronunciation>(AN-tee ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL R1 on the surface of some tumor cells.  This may kill the tumor cells. Anti-TRAIL R1-mAb is a type of monoclonal antibody. Also called HGS-ETR1 and mapatumumab.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725782" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anti-TRAIL R1-mAb&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725781" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anti-TRAIL R1-mAb&quot;" language="es" id="_4"/><SpanishTermName>anti-TRAIL R1-mAb</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de cáncer. Se une a una proteína de la superficie de algunas células tumorales que se llama TRAIL R1. Podría destruir células tumorales. El anti-TRAIL R1-mAb es un tipo de anticuerpo monoclonal. También se llama HGS-ETR1 y mapatumumab.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-05-19</DateFirstPublished></GlossaryTerm>
